Business Model:
Revenue: $0
Employees: 0-0
Leerink Partners was acquired by
Silicon Valley Bank.
The acquisition happend on 2018-11-13.
Details of the transaction were not public
Address:
City:
State:
Zip:
Country:
Leerink Partners is a leading investment bank, specializing in healthcare. Their knowledge, experience and focus enable us to help their clients define and achieve their strategic, capital markets and investment objectives. They partner with companies that develop and commercialize innovative products and services that are defining the future of healthcare.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2017 | Arcus Biosciences | Series C | 107M |
10/2009 | Humedica | Series A | 30M |
9/2018 | Fulcrum Therapeutics | Series B | 80M |
2/2018 | Generation Bio | Series B | 100M |
6/2018 | Precision BioSciences | Series B | 0 |
2/2013 | Living Proof | Series C | 30M |
6/2011 | TESARO | Series B | 101M |
9/2017 | Replimune Group | Series B | 55M |
7/2015 | Translate Bio | Series B | 0 |
2/2018 | Avrobio | Series B | 60M |
3/2017 | Solid Biosciences | Series C | 0 |
5/2019 | AlloVir | Series B | 120M |
8/2020 | Kinnate Biopharma | Series C | 98M |
5/2018 | FogPharma | Series B | 66M |
9/2015 | Kyruus | Series C | 25M |
4/2012 | Humedica | Venture Round | 10M |
8/2020 | Kinnate Biopharma | Series C | 0 |
5/2019 | AlloVir | Series B | 0 |
9/2018 | Fulcrum Therapeutics | Series B | 0 |
6/2018 | Precision BioSciences | Series B | 0 |
5/2018 | FogPharma | Series B | 0 |
2/2018 | Generation Bio | Series B | 0 |
2/2018 | Avrobio | Series B | 0 |
11/2017 | Arcus Biosciences | Series C | 0 |
9/2017 | Replimune Group | Series B | 0 |
3/2017 | Solid Biosciences | Series C | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|